GenapSys
Latest round
- Series D
Last raised
- Feb 2021
Total raised
- $155M
Investors
- 8
About GenapSys
Founded in 2010 and based in California, US, Genapsys, Inc. operates as a biotechnology company that develops a novel DNA sequencing technology and detection system for applied genomic testing and medical sequencing. Hesaam Esfandyarpour is the CEO, chairman, and founder of the company. The company provides GenapSys™ Sequencer, an electrical-based platform that enables to detect sequencing. This DNA-sequencing technology is used for research and testing genetic diseases, cancer, and microbes. The organization's platform enables academic and clinical researchers, molecular pathologists, and other physicians to gain easy access to genomic sequencing.
Who invested in GenapSys
8 investors across 3 rounds
See all investors in GenapSys
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GenapSys
Who invested in GenapSys?
GenapSys has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenapSys raised?
GenapSys has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GenapSys last raise money?
GenapSys's most recent round on record is a Series D, in Feb 2021.
What does GenapSys do?
Founded in 2010 and based in California, US, Genapsys, Inc.
Where is GenapSys headquartered?
GenapSys is headquartered in Redwood City, US.
Which VCs invest in companies like GenapSys?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at GenapSys's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like GenapSys? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.